Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.
$473.03M net income for the year ended June 26, 2026. These are reported results, not a forecast or a stock recommendation.
Latest-filed standard financial facts · USD
Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.
Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.
| Reported period | Reported value | Filed | Source |
|---|---|---|---|
| June 28, 2025 – June 26, 2026 | $4,641,097,000 | August 18, 2026 | 10-K ↗ |
| June 29, 2024 – June 27, 2025 | $3,419,327,000 | August 18, 2026 | 10-K ↗ |
| July 1, 2023 – June 28, 2024 | $2,882,967,000 | August 18, 2026 | 10-K ↗ |
| June 25, 2022 – June 30, 2023 | $2,645,237,000 | August 19, 2025 | 10-K ↗ |
| June 26, 2021 – June 24, 2022 | $2,262,224,000 | August 20, 2024 | 10-K ↗ |
| June 27, 2020 – June 25, 2021 | $1,879,350,000 | August 22, 2023 | 10-K ↗ |
| June 29, 2019 – June 26, 2020 | $1,641,836,000 | August 16, 2022 | 10-K ↗ |
| June 30, 2018 – June 28, 2019 | $1,584,335,000 | August 17, 2021 | 10-K ↗ |
One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.
Concept: us-gaap:Revenues · Retrieved October 8, 2026
Response SHA-256: c299c7a8c24069d6e44557df71252577811270f8ab57949cdd0eb63630d2948b
Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.